Abstract:The objectives were: (1) to develop a more rapid, reduced serum culture system for Caco-2 monolayers, relative to the traditional 21-day, 10% fetal bovine serum (FBS) system; and (2) to determine the biopharmaceutical drug classification of an oral therapeutic agent using this new system. Caco-2 cells were grown in the six well format on polycarbonate filters, in medium containing 2% iron supplemented calf serum (sCS) and a combination of growth factors and hormones. After 4 days in culture, permeabilities of three marker compounds (metoprolol, mannitol, and taurocholate) across monolayers were determined, and compared to permeabilities from the traditional 21-day, 10% FBS system, using cells at similar passage number. Cell morphology, degree of cell differentiation, and the presence of two efflux pumps were assessed. The 2% sCS model was also used to classify the permeability of an oral therapeutic agent as high or low. No difference in permeability was observed for metoprolol transport (P = 0.38) between the two culture methods, and the values obtained were independent of passage number of the cells. Mannitol permeability was about 2-fold higher from the 2% sCS system, as compared to the 10% FBS system. Taurocholate permeability was low indicating the 2% sCS culture at 4 days lacked this particular active transporter capability. Electron micrographs of cells grown in the 2% sCS system at 4 days revealed the presence of microvilli and tight junctions. P-glycoprotein and an efflux pump for furosemide were functionally present. The 2% sCS system indicated the oral therapeutic agent as highly permeable, which agreed with the 10% FBS system. This new system provides a rapid, accurate, and economical option for passive permeability determination, and appears to be applicable to the proposed Biopharmaceutics Classification System (BCS).

Poster Session 2 — Drug Delivery

Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis

Design of 3D printed insert for hanging culture of Caco-2 cells.

Permeability for Intestinal Absorption: Caco-2 Assay and Related Issues

Human enteroid monolayers as a potential alternative for Ussing chamber and Caco-2 monolayers to study passive permeability and drug efflux

Short Caco-2 model for evaluation of drug permeability: A sodium valerate-assisted approach

Characterization of Drug Permeability in Caco-2 Monolayers by Mass Spectrometry on A Membrane-Based Microfluidic Device

Development and validation of Caco-2 cell monolayer—model of intestinal transport

Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa

Towards Prediction of in Vivo Exposure from a Permeability Perspective Using a 96-Well Caco-2 Assay

Drug evaluations using a novel microphysiometer based on cell-based biosensors

Transepithelial Electrical Resistance is Not a Reliable Measurement of the Caco-2 Monolayer Integrity in Transwell

Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system

Mucin-Protected Caco-2 Assay to Study Drug Permeation in the Presence of Complex Biorelevant Media

Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.

Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices

A Dynamic Real-Time Method for Monitoring Epithelial Barrier Function in Vitro

Automated measurement of transepithelial electrical resistance (TEER) in 96-well transwells using ECIS TEER96: Single and multiple time point assessments

Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness

Validation of an Ex Vivo Permeation Method for the Intestinal Permeability of Different BCS Drugs and Its Correlation with Caco-2 In Vitro Experiments

Comprehensive characterization and optimization of Caco-2 cells enabled the development of a miniaturized 96-well permeability assay